The present invention relates to compounds of formula (I) ##STR00001## and their pharmaceutically acceptable salts, wherein R.sup.1, R.sup.2, R.sup.3 and Z are as defined herein, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders.